Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial

Farmer AJ. et al, (2024), Pilot and Feasibility Studies, 10

supporting people with type 2 diabetes diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial

FARMER A., (2024), Pilot and Feasibility Studies

Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial

Farmer A. et al, (2022), JMIR Research Protocols, 11

Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care to reduce cardiovascular risk (SuMMiT-D): an effectiveness and cost-effectiveness randomised control trial protocol

FARMER A. et al, (2021), JMIR Research Protocols

Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial (Preprint)

Farmer A. et al, (2021)

Frequency of Renal Monitoring - Creatinine and Cystatin C (FORM-2C): An observational cohort study of patients with reduced eGFR in primary care

Fleming S. et al, (2021), British Journal of General Practice, 71, E677 - E684

Long-term monitoring in primary care for chronic kidney disease and chronic heart failure: a multi-method research programme

Perera R. et al, (2021)

On-site monitoring of primary outcomes is important in primary care clinical trials: Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK-D) Trial a case study

Jones L. et al, (2019), TRIALS, 20

Self-Management Support Using a Digital Health System Compared With Usual Care for Chronic Obstructive Pulmonary Disease: Randomized Controlled Trial

Farmer A. et al, (2017), Journal of Medical Internet Research, 19

The role of Der p 1 specific T cells in atopic eczema

Chan HW. et al, (2013), AUSTRALASIAN JOURNAL OF DERMATOLOGY, 54, 13 - 14

Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus

Crack LR. et al, (2012), Clinical and Experimental Dermatology, 37, 534 - 543

Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus

Crack LR. et al, (2012), Clinical and Experimental Dermatology

Antigen dose and keratinocyte antigen presentation are specific determinants of T cell function in atopic eczema

Chan HW. et al, (2011), AUSTRALASIAN JOURNAL OF DERMATOLOGY, 52, 19 - 20

Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome

Aly L. et al, (2011), Brain, 134, 2687 - 2702

Frequencies of circulating allergen-specific T cells temporally associate with longitudinal changes in severity of cutaneous atopic disease

McPherson T. et al, (2010), Clinical and Experimental Dermatology, 35, 786 - 788

Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.

McPherson T. et al, (2010), Br J Dermatol, 163, 544 - 549

Natural Killer Cells During Primary Varicella Zoster Virus Infection.

Malavige GN. et al, (2010), J Infect

IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies

Malavige GN. et al, (2010), British Journal of Cancer, 102, 727 - 730

Tracking epitope-specific antiviral CD4+ T cell responses to a live attenuated vaccine reveals ongoing functional responses

Jones L. et al, (2009), Vaccine, 27, 7398 - 7401

Immune evasion during varicella zoster virus infection of keratinocytes.

Black AP. et al, (2009), Clin Exp Dermatol, 34, e941 - e944

Load More